TRPV1 and myeloid sarcoma: We also observed a significant increase in protein levels in the MS group, which was significantly decreased in the EA group (Fig. 2H and I; 99.46 ± 1.34; 97.98 ± 7.6, respectively, p < 0.05) and TRPV1−/− group (Fig. 2H and I; 101.3 ± 3.84; 95.99 ± 6.29, respectively, p < 0.05) compared with that in the MS group.